Masson, W. et al. Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: A meta-analysis and meta-regression. Lipids Health Dis. 19, 1–11 (2020).
Zdravkovic, S. et al. Heritability of death from coronary heart disease: A 36 year follow up of 20 966 swedish twins. J Inter. Med. 252, 247–254 (2002).
Google Scholar
Fischer, M. et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111, 855–862 (2005).
Google Scholar
van der Harst, P. & Verweij, N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ. Res. 122, 433–443 (2018).
Google Scholar
Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
Google Scholar
Aulchenko, Y. S. et al. Loci influencing lipid levels and coronary heart disease risk in 16 european population cohorts. Nat. Genet. 41, 47 (2009).
Google Scholar
Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009).
Google Scholar
Kettunen, J. et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat. Genet. 44, 269–276 (2012).
Google Scholar
Langlois, M. et al. European atherosclerosis society (eas) and the european federation of clinical chemistry and laboratory medicine (eflm) joint consensus initiative. Quantifying atherogenic lipoproteins: Current and future challenges in the era of personalized medicine and very low concentrations of ldl cholesterol. A consensus statement from eas and eflm. Clin. Chem. 64, 1006–1033 (2018).
Google Scholar
Sharifi, M., Futema, M., Nair, D. & Humphries, S. E. Genetic architecture of familial hypercholesterolaemia. Curr. Cardiol. Rep. 19, 44 (2017).
Google Scholar
Defesche, J. C. et al. Familial hypercholesterolaemia. Nat. Rev. Dis. Primers. 3, 1–20 (2017).
Jeemon, P., Pettigrew, K., Sainsbury, C., Prabhakaran, D. & Padmanabhan, S. Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J. Cardiol. 3, 230 (2011).
Google Scholar
Gu, Q. et al. Association between polymorphisms in the apob gene and hyperlipidemia in the chinese yugur population. Braz. J. Med. Biol. Res. 50, 11 (2017).
Mach, F. et al. 2019 esc/eas guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 41, 111–188 (2020).
Google Scholar
Kessler, T., Vilne, B. & Schunkert, H. The impact of genome wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol. Med. 8, 688–701 (2016).
Google Scholar
Brænne, I. et al. Prediction of causal candidate genes in coronary artery disease loci. Arteroscler. Thromb. Vasc. Biol. 35, 2207–2217 (2015).
Ritchie, M. D., Holzinger, E. R., Li, R., Pendergrass, S. A. & Kim, D. Methods of integrating data to uncover genotype–phenotype interactions. Nat. Rev. Genet. 16, 85–97 (2015).
Google Scholar
Hartiala, J. et al. The genetic architecture of coronary artery disease: Current knowledge and future opportunities. Curr. Atheroscler. Rep. 19, 6 (2017).
Google Scholar
Zhao, Y. et al. Multi-omics integration reveals molecular networks and regulators of psoriasis. BMC Sys. Biol. 13, 1–14 (2019).
Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Gen. Biol. 18, 1–15 (2017).
Arneson, D. et al. Multidimensional integrative genomics approaches to dissecting cardiovascular disease. Front Cardiovasc. Med. 4, 8 (2017).
Google Scholar
Manzoni, C. et al. Genome, transcriptome and proteome: The rise of omics data and their integration in biomedical sciences. Brief Bioinform. 19, 286–302 (2018).
Google Scholar
Faulkner, S., Dun, M. D. & Hondermarck, H. Proteogenomics: Emergence and promise. Cell. Mol. Life Sci. 72, 953–957 (2015).
Google Scholar
Thomas, P. G. et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111(5), 697–716 (2005).
Marc-Andr, C. et al. Scientific statement from the American Heart Association. Circulation 124(18), 1996–2019 (2011).
McKiernan, H. & Danielson, P. Molecular Diagnostics 371–394 (Elsevier, 2017).
Alyethodi, R. R. et al. T-arms pcr genotyping of snp rs445709131 using thermostable strand displacement polymerase. BMC Res. Note 11, 1–5 (2018).
Bradford, M. Nothofagus. J. Forest. 73, 248–249 (1979).
Mirza, M. R. et al. A novel strategy for phosphopeptide enrichment using lanthanide phosphate co-precipitation. Anal. Bioanal. Chem. 404, 853–862 (2012).
Google Scholar
Beltran-Camacho, L. et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res. Ther. 11(1), 1591 (2020).
Cox, J. et al. Andromeda: A peptide search engine integrated into the maxquant environment. J. Proteome. Res. 10, 1794–1805 (2011).
Google Scholar
Cox, J. & Matthias, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotech. 26, 1367–1372 (2008).
Google Scholar
Christian, L. A. et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32(2), 279–289 (2010).
Green, G. H. & Diggle, P. J. On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure. Stat. Appl. Genet. Mol. Biol. 6, 1302 (2007).
Google Scholar
Szklarczyk, D. et al. The string database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, 561–568 (2010).
Kurakin, A. Scale-free flow of life: On the biology, economics, and physics of the cell. Theor. Biol. Medical. Model. 6, 1–28 (2009).
Gutteridge, A. et al. Nutrient control of eukaryote cell growth: A systems biology study in yeast. BMC Biol. 8, 1–20 (2010).
Bensimon, A., Heck, A. J. & Aebersold, R. Mass spectrometry-based proteomics and network biology. Annu. Rev. Biochem. 81, 379–405 (2012).
Google Scholar
Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161–169 (2008).
Google Scholar
Katzung, B. G. Basic and Clinical Pharmacology, (12th edition) 609–610 (Mc Graw Hill Education, 2012).
Lettre, G. et al. Genome-wide association study of coronary heart disease and its risk factors in 8,090 african americans: The nhlbi care project. PLoS Genet. 7, e1001300 (2011).
Google Scholar
Choi-Miura, N. H. Quantitative measurement of the novel human plasma protein, ihrp, by sandwich elisa. Biol. Pharm. Bull. 24, 214–217 (2012).
Sandhu, M. S. et al. Ldl-cholesterol concentrations: A genome-wide association study. The Lancet 371, 483–491 (2008).
Google Scholar
Piñeiro, M. et al. ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma hepg2 cells. Biochem. Biophys. Res. Commun. 263, 224–229 (1999).
Google Scholar
Kashyap, R. S. et al. Inter-α-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin. Chim. Acta. 402, 160–163 (2009).
Google Scholar
Villanueva, J. et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Investig. 116, 271–284 (2006).
Google Scholar
van Winden, A. W. et al. Serum degradome markers for the detection of breast cancer. J. Proteome. Res. 9, 3781–3788 (2010).
Google Scholar
Song, J. et al. Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. Clin. Chem. 52, 1045–1053 (2006).
Google Scholar
Tolosano, E. & Altruda, F. Hemopexin: Structure, function, and regulation. DNA Cell Biol. 21, 297–306 (2002).
Google Scholar
Kumar, S. & Bandyopadhyay, U. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175–188 (2005).
Google Scholar
Tolosano, E., Fagoonee, S., Morello, N., Vinchi, F. & Fiorito, V. Heme scavenging and the other facets of hemopexin. Antioxid. Redox Signal. 12, 305–320 (2010).
Google Scholar
Balla, J. et al. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol. Nutr. Food Res. 49, 1030–1043 (2005).
Google Scholar
Vaisar, T. et al. Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans. Curr. Atheroscler. Rep. 9, 417–424 (2007).
Google Scholar
Bratti, L. D. O. S. et al. Complement component 3 (c3) as a biomarker for insulin resistance after bariatric surgery. Clin. Biochem. 50, 529–532 (2017).
Google Scholar
Ahmad, R. M. H. & Al-Domi, H. A. Complement 3 serum levels as a pro-inflammatory biomarker for insulin resistance in obesity. Diabetes Metab. Syndr. 11, S229–S232 (2017).
Ursini, F. & Abenavoli, L. The emerging role of complement c3 as a biomarker of insulin resistance and cardiometabolic diseases: Preclinical and clinical evidence. Rev. Recent Clin. Trials. 13, 61–68 (2018).
Google Scholar
Martin-Fernandez, L. et al. The unravelling of the genetic architecture of plasminogen deficiency and its relation to thrombotic disease. Sci. Rep. 6, 1–7 (2016).
Mehta, R. & Shapiro, A. Plasminogen deficiency. Haemophilia 14, 1261–1268 (2008).
Google Scholar
Folsom, A. R. Fibrinolytic factors and atherothrombotic events: Epidemiological evidence. Ann. Med. 32, 85–91 (2000).
Google Scholar
Stankiewicz, A. M. et al. Social stress increases expression of hemoglobin genes in mouse prefrontal cortex. BMC Neurosci. 15, 1–16 (2014).
Hristov, M. et al. Importance of cxc chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100, 590–597 (2007).
Google Scholar
Majumdar, S., Gonder, D., Koutsis, B. & Poncz, M. Characterization of the human beta-thromboglobulin gene: Comparison with the gene for platelet factor 4. J. Biol. Chem. 266, 5785–5789 (1991).
Google Scholar
Maneerat, Y., Prasongsukarn, K., Benjathummarak, S. & Dechkhajorn, W. Ppbp and defa1/defa3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease. Lipids Health Dis. 16, 1–12 (2017).
Rocha, N. A., East, C., Zhang, J. & McCullough, P. A. Apociii as a cardiovascular risk factor and modulation by the novel lipid-lowering agent volanesorsen. Curr. Atheroscler. Rep. 19, 1–9 (2017).
Google Scholar
TGH Group. Working group of the exome sequencing project, national heart, lung, and blood institute, Loss-of-function mutations in apoc3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22–31 (2014).
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G. & Tybjærg-Hansen, A. Loss-of-function mutations in apoc3 and risk of ischemic vascular disease. N. Engl. J. Med. 371, 32–41 (2014).
Google Scholar
Tani, S., Takahashi, A., Nagao, K. & Hirayama, A. Association of lecithin–cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: A cross-sectional study. Heart Vessels 31, 831–840 (2016).
Google Scholar
Yokoyama, K., Tani, S., Matsuo, R. & Matsumoto, N. Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: A longitudinal pilot study. BMC Cardiovasc. Disord. 18, 1–10 (2018).
Ahmed, M., Jadhav, A., Hassan, A. & Meng, Q. H. Acute phase reactants as novel predictors of cardiovascular disease. Int. Sch. Res. Notices. 2012, 1–8 (2012).
Vélez, P. & García, A. Platelet proteomics in cardiovascular diseases. Transl. Proteom. 7, 15–29 (2015).
Sharony, R. et al. Protein targets of inflammatory serine proteases and cardiovascular disease. J. Inflamm. 7, 1–17 (2010).
Granger, D. N., Vowinkel, T. & Petnehazy, T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 43, 924–931 (2004).
Google Scholar
Mügge, A. et al. Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. Circ. Res. 69, 871–880 (1991).
Google Scholar
Marcondes, S. & Antunes, E. The plasma and tissue kininogen-kallikrein-kinin system: Role in the cardiovascular system. Curr. Med. Chem. Cardiovasc. Hematol. Agents. 3, 33–44 (2005).
Google Scholar
Pejler, G., Rönnberg, E., Waern, I. & Wernersson, S. Mast cell proteases: Multifaceted regulators of inflammatory disease. Blood 115, 4981–4990 (2010).
Google Scholar
